Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Sutro Biopharma (STRO) Non Operating Income (2017 - 2025)

Historic Non Operating Income for Sutro Biopharma (STRO) over the last 4 years, with Q3 2025 value amounting to -$8.4 million.

  • Sutro Biopharma's Non Operating Income fell 14389.5% to -$8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$28.9 million, marking a year-over-year decrease of 24982.86%. This contributed to the annual value of $13.4 million for FY2024, which is 187267.36% up from last year.
  • Latest data reveals that Sutro Biopharma reported Non Operating Income of -$8.4 million as of Q3 2025, which was down 14389.5% from -$8.2 million recorded in Q2 2025.
  • Sutro Biopharma's Non Operating Income's 5-year high stood at $19.1 million during Q3 2024, with a 5-year trough of -$8.4 million in Q3 2025.